Krystal Biotech Inc — 四半期キャッシュフロー (NASDAQ:KRYS) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 1.06 B1.07 B1.14 B1.24 B1.33 B 負債合計 109.46 M89.74 M97.75 M102.22 M114.23 M 純資産合計 946.38 M984.67 M1.04 B1.14 B1.22 B 負債および純資産合計 1.06 B1.07 B1.14 B1.24 B1.33 B 有利子負債合計 ————— 純負債 —————

ニュース

OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch

Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report?

Krystal Biotechの社長Krishnan Krish S氏、KRYS株658万ドル相当を売却

Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock

Krystal Biotechの取締役Krishnanが658万ドル相当の株式を売却

Krystal Biotech director Krishnan sells $6.58 million in shares

Krystal Biotechの戦略的成長と課題:TD Cowenカンファレンスにて

Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges

Daniel JanneyがKrystal Biotech（KRYS）株325万ドル相当を売却

Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million